Adamas Biotech, a newly created startup of which Cube Labs is the main controller, is the result of a collaboration between INBB (National Institute of Biostructures and Biosystems) and the University of Parma.
The goal of Adamas Biotech project is to use at best all the natural properties of the green tea catechins for the realization of complete product lines both for the consumer market and for the healthcare market.
For the consumer market, Adamas Biotech will produce cosmetics and anti-aging products. With regards to the healthcare market, the startup plans to start the production of wound care, products for trichology and products for prostate cancer prevention.
Furthermore, Adamas Biotech startup is involved in the characterisation and isolation of “exosomes“.